Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cashflow Statement

AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹342 Cr₹120 Cr₹-161 Cr₹441 Cr₹884 Cr
Adjustment ₹1,373 Cr₹1,276 Cr₹1,136 Cr₹787 Cr₹478 Cr
Changes In working Capital ₹-488 Cr₹-234 Cr₹-302 Cr₹-292 Cr₹-620 Cr
Cash Flow after changes in Working Capital ₹1,227 Cr₹1,161 Cr₹673 Cr₹936 Cr₹742 Cr
Cash Flow from Operating Activities ₹892 Cr₹1,005 Cr₹484 Cr₹766 Cr₹598 Cr
Cash Flow from Investing Activities ₹-477 Cr₹-434 Cr₹-1,339 Cr₹-1,812 Cr₹-4,480 Cr
Cash Flow from Financing Activities ₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr
Net Cash Inflow / Outflow ₹-26 Cr₹148 Cr₹-37 Cr₹-251 Cr₹94 Cr
Opening Cash & Cash Equivalents ₹219 Cr₹53 Cr₹85 Cr₹262 Cr₹152 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ---₹77 Cr-
Cash & Cash Equivalent of Subsidiaries under liquidations ----₹11 Cr
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-11 Cr₹18 Cr₹5.15 Cr₹-2.04 Cr₹4.22 Cr
Closing Cash & Cash Equivalent ₹182 Cr₹219 Cr₹53 Cr₹85 Cr₹262 Cr

Compare Cashflow Statement of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹18,489.2 Cr -10.4% -16.2% -31.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-10.4%

-16.2%

-31.2%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses